marizomib: Clinical Trials

5 trials of marizomib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated, 1 withdrawn. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Terminated 1, Withdrawn 1
Phase 11Completed 1

Follow marizomib: new trials by email Literature Review of marizomib trials Research Report on marizomib

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Marizomib Central Nervous System (CNS)
Marizomib, Pomalidomide, Dexamethasone - Multiple Myeloma, Multiple Myeloma in Relapse
Phase 2WithdrawnDana-Farber Cancer Institute2024-03-012024-07-16
Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma
Marizomib - Anaplastic Ependymoma, Ependymoma
Phase 2TerminatedNational Cancer Institute (NCI)42020-01-222022-07-27
Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma
nab-sirolimus, nab-sirolimus + temozolomide, nab-sirolimus + bevacizumab - High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma
Phase 2CompletedAadi Bioscience, Inc.622018-08-012023-11-07
Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab
MRZ, BEV - Malignant Glioma, Glioblastoma
Phase 1 / Phase 2CompletedCelgene1212015-04-152022-06-08
Phase 2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
MRZ 0.5 mg/m^2 - Multiple Myeloma
Phase 2CompletedCelgene152007-03-012017-12-19

Conditions studied

Multiple Myeloma (2)  ·  Brain Neoplasms (1)  ·  Disease Progression (1)  ·  Ependymoma (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Gliosarcoma (1)  ·  Recurrence (1)

Sponsors

Celgene (2)  ·  Aadi Bioscience, Inc. (1)  ·  Dana-Farber Cancer Institute (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (5)  ·  Canada (1)

Top investigators

Clifton Mo, MD (1)  ·  Ileana Elias, MD (1)  ·  Mark R Gilbert, M.D. (1)  ·  Steven D Reich, MD (1)

Results publications

PMID 27009059